phenylbutazone has been researched along with Coronary Disease in 13 studies
Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MATTHES, K | 1 |
| FOX, SL | 1 |
| EISEN, MJ | 1 |
| SERANE, J | 1 |
| PEAN, C | 1 |
| Aggeler, PM | 1 |
| O'Reilly, RA | 1 |
| Leong, L | 1 |
| Kowitz, PE | 1 |
| Halawa, B | 1 |
| Mazurek, W | 1 |
| Boss, GR | 1 |
| Seegmiller, JE | 1 |
| Ermalinskiĭ, AF | 2 |
| Balakin, AK | 2 |
| Iukhnovets, RA | 1 |
| Vedenina, RF | 1 |
| Miakin'kova, MI | 1 |
| Gormsen, J | 1 |
| Andersen, LA | 1 |
| Kliachkin, LM | 1 |
| Parshina, ZS | 1 |
| Mit'kin, AF | 1 |
| Sitar, J | 2 |
1 review available for phenylbutazone and Coronary Disease
| Article | Year |
|---|---|
Hyperuricemia and gout. Classification, complications and management.
Topics: Acute Disease; Allopurinol; Arthritis; Aspirin; Colchicine; Coronary Disease; Diuretics; Gout; Human | 1979 |
12 other studies available for phenylbutazone and Coronary Disease
| Article | Year |
|---|---|
[Therapy of acute coronary thrombosis].
Topics: Anti-Arrhythmia Agents; Anticoagulants; Cardiotonic Agents; Coronary Disease; Coronary Thrombosis; D | 1958 |
POTENTIATION OF ANTICOAGULANTS CAUSED BY PYRAZOLE COMPOUNDS.
Topics: Anticoagulants; Blood Chemical Analysis; Chemical Phenomena; Chemistry; Coronary Disease; Gout; Hema | 1964 |
COMBINED EFFECT OF SODIUM WARFARIN AND PHENYLBUTAZONE.
Topics: Arthritis; Coronary Disease; Geriatrics; Hemorrhage; Oxyphenbutazone; Phenylbutazone; Prothrombin Ti | 1964 |
[OBSERVATIONS OF COMPLICATIONS OCCURRING IN GOUT PATIENTS DURING TREATMENT].
Topics: Adrenal Cortex Hormones; Coronary Disease; Cortisone; Depression; Drug Therapy; Erectile Dysfunction | 1965 |
Potentiation of anticoagulant effect of warfarin by phenylbutazone.
Topics: Adolescent; Adult; Aged; Blood Coagulation; Coronary Disease; Drug Synergism; Humans; Male; Middle A | 1967 |
[Interactions of digoxin and the nonsteroidal anti-inflammatory drugs, acetylsalicylic acid and nifedipine].
Topics: Adult; Arthritis; Aspirin; Coronary Disease; Digoxin; Drug Interactions; Humans; Indomethacin; Male; | 1982 |
[Effect of butadione on lipid metabolism in chronic ischemic heart disease patients].
Topics: Chronic Disease; Coronary Disease; Dipyridamole; Drug Evaluation; Drug Therapy, Combination; Humans; | 1986 |
[Tolerance of physical exertion among patients with chronic ischemic heart disease during treatment with butadione].
Topics: Adolescent; Adult; Aged; Coronary Disease; Female; Humans; Male; Middle Aged; Phenylbutazone; Physic | 1986 |
[Incidence of thrombosis and the status of coagulation in ischaemic heart disease].
Topics: Acute Disease; Aspirin; Blood Coagulation; Chronic Disease; Coronary Disease; Depression, Chemical; | 1974 |
[Effect of butadion on certain indices of hemostatic function in patients with coronary insufficiency].
Topics: Adult; Aged; Angina Pectoris; Blood Coagulation; Coronary Disease; Humans; Middle Aged; Myocardial I | 1969 |
[Effect of gamma-ketophenylbutazone (Ketazon SPOFA) on the level of serum cholesterol].
Topics: Adult; Aged; Arteriosclerosis; Cholesterol; Coronary Disease; Female; Humans; Hypercholesterolemia; | 1968 |
[Further experiences with suppression of anginal pain with ketophenylbutazone].
Topics: Angina Pectoris; Anticholesteremic Agents; Cholesterol; Coronary Disease; Humans; Male; Middle Aged; | 1968 |